1-3 of 3
Raja Luthra, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Significance of Molecular Monitoring in Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with Imatinib Therapy.

Jorge Cortes, M.D., Moshe Talpaz, M.D., Susan O’Brien, M.D., Dan Jones, M.D., Ph.D., Raja Luthra, Ph.D., Guillermo Garcia-Manero, M.D., Francis Giles, M.D., Jenny Shan, Ph.D., Srdan Verstovsek, M.D., Ph.D., Mary Beth Rios, R.N., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2004) 104 (11): 272.
https://doi.org/10.1182/blood.V104.11.272.272
Published: 2004
Journal Articles

Imatinib Mesylate for Patients (pts) with Hypereosinophilic Syndrome (HES) and Systemic Mastocytosis (SM): A Phase II Trial.

Elias Jabbour, M.D., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D., Dan Jones, Ph.D., M.D., Susan O’Brien, M.D., Raja Luthra, Ph.D., Farhad Ravandi-Kashani, M.D., William Wierda, M.D., Francis Giles, M.D., Mary Beth Rios, R.N., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 4752.
https://doi.org/10.1182/blood.V104.11.4752.4752
Published: 2004
Journal Articles

Long-Term Incidence and Outcome of BCR-ABL Mutations in Patients (pts) with Chronic Myeloid Leukemia (CML) Treated with Imatinib Mesylate - P-Loop Mutations Are Not Associated with Worse Outcome.

Elias Jabbour, M.D., Hagop Kantarjian, M.D., Dan Jones, Ph.D., M.D., Susan O’Brien, M.D., Raja Luthra, Ph.D., Guillermo Garcia-Manero, M.D., Francis Giles, M.D., Mary Beth Rios, R.N., Srdan Verstovsek, M.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 1007.
https://doi.org/10.1182/blood.V104.11.1007.1007
Published: 2004